Source documents · Archived capture
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
Archived web capture. Preserved source — captured from www.globenewswire.com; archived 2026-09-28.
The original is not available for public download.
Original: globenewswire.com
Record facts
| File name | emergent-biosolutions-signs-five-year-agreement-for-large-scale-drug-s_3d3ba8eea9b906f9.html |
|---|---|
| SHA-256 | 0c445a2b0dc55b2aa455016d9b793ed402d68bd4c724b6f216a0b0009057bb69 |
| Size | 68,779 bytes |
| Captured | 2026-09-28 |
| Source site | www.globenewswire.com |